Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IY2V
|
||||
Former ID |
DNC007676
|
||||
Drug Name |
MCL-445
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528787] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H33N3O
|
||||
Canonical SMILES |
CNC(=O)NC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CCC5)C=C1
|
||||
InChI |
1S/C23H33N3O/c1-24-22(27)25-18-9-8-17-13-21-19-7-2-3-10-23(19,20(17)14-18)11-12-26(21)15-16-5-4-6-16/h8-9,14,16,19,21H,2-7,10-13,15H2,1H3,(H2,24,25,27)/t19-,21+,23+/m0/s1
|
||||
InChIKey |
URMRSPJBIISGIL-XKCSPQBFSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528787] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528787] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [528787] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.